Concert’s CTP-543 Shows Advantages Over Lilly, Pfizer Candidates For Alopecia

 
• By Joseph Haas
Front view of a balding woman before and after hair treatment. Divided image of the head. Two halves. Sticker revealing healthy scalp. Female alopecia. Isolated vector illustration.
Concert is vying with Lilly and Pfizer in the unmet alopeic areata indication

More from Clinical Trials

More from R&D